India Entry & Business Startup Consultings

Recommendations of 44th GST Council Meeting

The 44th GST Council met under the Chairmanship of Union Finance & Corporate Affairs Minister Smt Nirmala Sitharaman through video conferencing held on 12th June, 2021. The Council in its meeting has decided to reduce the GST rates on the specified items being used in Covid-19 relief and management till 30 September, 2021.

The details of recommendations are:

A. MEDICINE

S. No.

Description

Present GST Rate

GST Rate recommended by GST Council

1

Tocilizumab

5%

Nil

2

Amphotericin B

5%

Nil

3

Anti-Coagulants like Heparin

12%

5%

4

Remdesivir

12%

5%

5

Any other drug recommended by Ministry of Health and Family Welfare (MoHFW) and Dept. of Pharma (DoP) for Covid treatment

Applicable Rate

5%

 

B. OXYGEN, OXYGEN GENERATION EQUIPMENT AND RELATED MEDICAL DEVICES

S. No.

Description

Present GST Rate

GST Rate recommended by GST Council

1

Medical Grade Oxygen

12%

5%

2

Oxygen Concentrator/ Generator, including personal imports thereof

12%

5%

3

Ventilators

12%

5%

4

Ventilator masks / canula / helmet

12%

5%

5

BiPAP Machine

12%

5%

6

High flow nasal canula (HFNC) device

12%

5%

 

C. TESTING KITS AND MACHINES

S. No.

Description

Present GST Rate

GST Rate recommended by GST Council

1

Covid Testing Kits

12%

5%

2

Specified Inflammatory Diagnostic Kits, namely D-Dimer, IL-6, Ferritin and LDH

12%

5%

 

D. OTHER COVID-19 RELATED RELIEF MATERIAL

S. No.

Description

Present GST Rate

GST Rate recommended by GST Council

1

Pulse Oximeters, incl personal imports thereof

12%

5%

2

Hand Sanitizer

18%

5%

3

Temperature check equipment

18%

5%

4

Gas/Electric/other furnaces for crematorium, including their installation, etc.

18%

5%

5

Ambulances

28%

12%

 

These rate reductions/exemptions shall remain in force up to 30th September 2021.

Source: https://pib.gov.in/PressReleasePage.aspx?PRID=1726525

 

Leave a Reply

Your email address will not be published. Required fields are marked *

 

SUBSCRIBE OUR NEWS LETTER